Abstract. The bioartificial kidney (BAK) consists of a conventional hemofiltration cartridge in series with a renal tubule assist device (RAD) containing 10 9 porcine renal proximal tubule cells. BAK replaces filtration, transport, and metabolic and endocrinologic activities of a kidney. Previous work in an acutely uremic dog model demonstrated that BAK ameliorated endotoxin (lipopolysaccharide [LPS])-induced hypotension and altered plasma cytokine levels. To further assess the role of BAK in sepsis in acute renal failure, dogs were nephrectomized and 48 h later administered intraperitoneally with 30 ϫ 10 10 bacteria/kg of E. coli. One hour after bacterial administration, animals were placed in a continuous venovenous hemofiltration circuit with either a sham RAD without cells (n ϭ 6) or a RAD with cells (n ϭ 6). BP, cardiac output, heart rate, pulmonary capillary wedge pressure, and systemic vascular resistance were measured throughout the study. All animals tested were in renal failure, with blood urea nitrogen and serum creatinine concentrations greater than 60 and 6 mg/dl, respectively. RAD treatment maintained significantly better cardiovascular performance, as determined by arterial BP (P Ͻ 0.05) and cardiac output (P Ͻ 0.02), for longer periods than sham RAD therapy. Consistently, all sham RAD-treated animals, except one, expired within 2 to 9 h after bacterial administration, whereas all RAD-treated animals survived more than 10 h. Plasma levels of TNF-␣, IL-10, and C-reactive protein (CRP) were measured during cell RAD and sham RAD treatment. IL-10 levels were significantly higher (P Ͻ 0.01) during the entire treatment interval in the RAD animals compared with sham controls. These data demonstrated in a pilot large animal experiment that the BAK with RAD altered plasma cytokine levels in acutely uremic animals with septic shock. This change was associated with improved cardiovascular performance and increased survival time. These results demonstrate that the addition of cell therapy to hemofiltration in an acutely uremic animal model with septic shock ameliorates cardiovascular dysfunction, alters systemic cytokine balance, and improves survival time.
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The development of acute renal failure (ARF) in a hospitalized patient results in a 5-to 8-fold higher risk of death (1, 2) . Although hemodialysis or hemofiltration treatment with its small solute and fluid clearance function has prevented death from hyperkalemia, volume overload, and uremic complications, such as pericarditis, patients with ARF still have mortality rates exceeding 50%.
Acute renal failure secondary to ischemic and/or nephrotoxic causes arises from acute tubular necrosis (ATN), predominantly to renal proximal tubule cells. Replacement of the functions of these cells during the episode of acute tubular necrosis would provide almost full renal replacement therapy in conjunction with hemofiltration. The addition of metabolic activity, such as ammoniagenesis and glutathione reclamation; endocrine activity, such as vitamin D 3 activation; and cytokine homeostasis may provide additional physiologic replacement activities to change the current natural history of this disease process (3).
Our laboratory has developed an extracorporeal device using a standard hemofiltration cartridge containing approximately 10 9 renal tubule cells grown as confluent monolayers along the inner surface of the fibers (4 -8) . The nonbiodegradability and the pore size of the hollow fibers allow the membranes to act as scaffolds for the cells and as an immunoprotective barrier. In vitro studies of this renal tubule assist device (RAD) have shown that the cells retain differentiated active transport properties, differentiated metabolic activities, and important endocrine processes (6) . Further studies have shown that the RAD, when incorporated in series with a hemofiltration cartridge in an extracorporeal blood perfusion circuit to formulate a bioartificial kidney (BAK), replaces filtration, transport, metabolic, and endocrine functions of the kidney in acutely uremic dogs (7) . Studies from our laboratory have also shown that the RAD ameliorates endotoxin shock secondary to intravenous infusion of lipopolysaccharide (LPS) in acutely uremic animals (9) .
To further assess the role of the RAD and the BAK in sepsis in acute renal failure, nephrectomized dogs were challenged with intraperitoneal administration of 30 ϫ 10 10 /kg body weight of E. coli bacteria followed by treatment with a cell containing RAD or sham RAD cartridge. This report summarizes an initial pilot animal study to assess the influence of the RAD on various cardiovascular and biochemical parameters in this model and tests the hypothesis that renal cell therapy in a BAK would add metabolic renal function, be associated with changes in systemic cytokine balance, and provide a survival advantage in a uremic animal model of septic shock.
Materials and Methods
Mongrel dogs weighing approximately 20 to 25 kg were fed a low-protein diet for seven days before being used for this experimental protocol, as previously reported (7) (8) (9) . Animals underwent bilateral nephrectomy to produce an acute uremic state. After surgery, they were permitted to eat and drink ad libitum for 48 h. The water and salt ingestion during this recovery period was no different between the two groups, because the filling pressures to both the left and right ventricles were similar in both groups at baseline at the beginning of the experimental protocol. Blood samples for electrolytes and complete blood counts were obtained before the low-protein diet, before surgery, and on postoperative days 1 and 2. The animals were sedated with thiopental sodium (Abbot Laboratories, North Chicago, IL), intubated, and administered isofluorane (Baxter Healthcare, Deerfield, IL) general anesthesia via endotracheal tube. An esophageal thermometer was inserted, and temperature was monitored. A dialysis catheter (Bard Access Systems, Salt Lake City, UT) was inserted via external jugular vein into the right atrium. An arterial catheter (Arrow International, Reading, PA), a venous catheter (Diag, Minnetonka, MN), and a Swan-Ganz thermodilution cardiac output catheter (Argon Medical, Athens, TX) were placed and transduced. Arterial, central venous, and pulmonary artery waveforms, as well as pulmonary capillary wedge pressure (PCWP) were measured (Model Viridia 24C; Hewlett-Packard GmbH, Böblinge, Germany) before institution of continuous venovenous hemofiltration (CVVH) and at hourly intervals thereafter. Cardiac outputs were measured by thermodilution (Model COM-1; American Hospital Supply, Irvine, CA) before CVVH and at hourly intervals thereafter. CVVH was interrupted and the dialysis lines clamped during cardiac output and PCWP measurements. BP, pulse, and temperature were recorded at 15-min intervals. Blood aliquots were obtained at various time interval hours for serum chemistries, blood counts, cytokine measurements, and endotoxin levels.
After all access lines were secured in the animal and baseline parameters and laboratory studies obtained, 100 ml of broth containing 30 ϫ 10 10 E. coli/kg was instilled into the animals' peritoneal cavities by means of a small take-down of the nephrectomy incision. The E. coli strain was serotype 06:K2:H1 (ATCC, Manassas, VA). This model was chosen because it has been used as a model of Gram-negative sepsis in other canine studies (10, 11) . To ensure that similar doses of bacteria were administered to each animal, the concentration of primary cultured bacteria was quantified for each experiment by plating 2.5 ϫ 10 6 -fold dilutions on nutrient agar and counting visible colonies after 24-h incubation at 37°C.
Within 1 h after bacterial insult, CVVH was instituted (Gambro AK-10; Gambro Lundia AB, Sundsvall, Sweden) with an F-40 hollow-fiber dialyzer (Fresenius, Walnut Creek, CA). Extracorporeal blood flow was regulated at 120 ml/min. Ultrafiltrate production was monitored, and a balanced electrolyte replacement solution was infused on a 1:1 volume replacement basis. In addition to the conventional CVVH circuit, a RAD containing porcine proximal tubule cells (cell RAD) or an otherwise identically treated hollow-fiber dialyzer without proximal tubule cells (sham RAD) was introduced. The tubule cells seeded into the RAD had been passaged 3 to 4 times. Alkaline phosphatase and ␣-glutamyltransferase immunostaining demonstrated that more than 95% of the cells were positive for these proximal tubule cell markers, and CD45 white blood cell marker was negative in the cell preparation. Six dogs were used in the cell RAD group and six dogs in the sham RAD group. RAD fabrication has been described in detail elsewhere (6 -8) . This fabrication is based on an F40 Fresenius hemofiltration cartridge comprised of 4950 polysulphone hollow fibers with an inner diameter of 200 m, a total diameter of 240 m, and a molecular weight cut-off of 45,000 daltons. Fourteen ml/min of ultrafiltrate from the hemofilter was directed into the luminal space of the RAD, and thus into direct contact with cultured porcine proximal tubule cells or polysulfone hemodialysis membranes, in the cell RAD and the sham RAD, respectively. Of the 120 ml/min blood flow through the hemofilter, 80 ml/min of post-hemofilter blood was directed into the extraluminal space of the RAD. Ultrafiltration rates were maintained at 14 ml/min. Transmural and hydraulic pressure gradients in the RAD were adjusted to maintain a reabsorption rate of 7 ml/min of ultrafiltrate into the post-hemofilter extracapillary blood compartment.
Animals with sham RAD and cell RAD were resuscitated identically according to a standard protocol (10, 11) . To simulate human septic shock therapy, all dogs received intravenous ceftriaxone sodium (100 mg/kg; Roche Laboratories, Nutleg, NJ) at hour 1 after bacterial administration. Volume resuscitation with 80 ml/kg of crystalloid in 20 ml/kg boluses was administered when the animal's mean arterial pressure declined below 70 mmHg and was accompanied by a PCWP below 15 mmHg. When systemic hypotension persisted after a cumulative dose of 80 ml/kg of crystalloid had been administered, and filling pressures as estimated by PCWP remained low, 80 ml/kg of colloid (Hespan; B. Braun, Bethlehem, PA) in divided 20 ml/kg boluses was also administered. All dogs received this complete volume resuscitation regimen within the first hour after bacteria seeding. No animals received vasopressor or inotropic agents. Animals were observed until no variation in arterial pressure waveform could be detected or until 15 h had elapsed and were then euthanized. Blood samples were drawn from animals of both groups during various time intervals of the experiment for measurement of levels of endotoxin, chemistries, cytokines, and 1,25-(OH) 2 vitamin D 3.
Assays
Serum chemistries were measured with an automated chemical analyzer (Synchron CX-7; Beckman Instruments, Brea, CA). IL-10 and TNF-␣ levels in the serum samples were evaluated in triplicate by ELISA. Anti-human IL-10 and anti-human TNF-␣ antibodies, the kind gift of Dr. Robert Streiter (University of Michigan, Ann Arbor, MI), showed a strong cross-species affinity with cytokines produced by both porcine and canine LPS-stimulated monocytes in culture. C-reactive protein levels were also measured using a commercially available ELISA assay kit (Tri-Delta Diagnostics, Morris Plains, NJ). Levels of 1,25-(OH) 2 vitamin D 3 were measured with two commercially available kits, an ELISA assay (American Laboratory Products Co., Windham, NH) and a 1,25 RIA (DiaSorin, Stillwater, MN). Endotoxin levels were determined with an assay kit (BioWhitaker, Walkersville, MD).
Statistical Analyses
Cardiovascular and cytokine data were analyzed by repeated-measures ANOVA over all time points. Endotoxin levels, plasma levels of solutes, and survival times were compared utilizing t test, paired or nonpaired as appropriate.
Results
The two groups of animals achieved nearly identical degrees of acute uremia after bilateral nephrectomies, as detailed in Table 1 . The degree of small solute clearance achieved during the treatment periods with the extracorporeal CVVH circuit were also similar between the two groups ( Table 1) . Both groups achieved significant reductions in blood urea nitrogen (BUN) and plasma creatinine levels with hemofiltration using either cell or sham RAD.
The levels of endotoxin in blood after E. coli infusion did not differ significantly between the two groups during the time course of the experiments, as displayed in Figure 1 . The cardiovascular parameters in the sham RAD and cell RAD groups are summarized in Table 2 . Cardiac outputs in the cell-treated group were significantly higher than in the shamtreated group (Figure 2 ; P Ͻ 0.02). Cardiac output was substantially better maintained in the cell RAD animals compared with the sham RAD animals throughout the entire treatment period. This improved cardiac output was not associated with differences in ventricular filling pressures, as reflected by comparable PCWP in both groups (Table 2) . With this improved cardiac contractility, systolic BP were significantly higher in the cell-treated versus the sham-treated group ( Figure  3 ; P Ͻ 0.05). The divergence of this physiologic parameter was apparent only after hour 4 of the experimental protocol. Mean arterial pressures, diastolic BP, and systemic vascular resistances were not different between the groups (Table 2) . These improved cardiovascular parameters translated into a significant survival advantage in the RAD group compared to the control sham group (Figure 4 , P Ͻ 0.02). The RAD animals survived 13.0 Ϯ 0.7 h versus 9.7 Ϯ 0.5 h in the sham controls.
The durability and viability of the cell RAD during exposure to animals in uremia and septic shock was assessed. Tubule cell counts in the processed ultrafiltrate exiting the RAD were quantitated hourly during the experiment. The total number of cells released during the entire experimental interval averaged less than 8 ϫ 10 6 cells, or less than 0.1% of the total number of cells in the device. Similar to previous studies, most of the cell loss occurred during the first hour of use of the device, when the less adherent cells are washed out of the device. Metabolic activity of the cells in the BAK was assessed by measuring the plasma levels of 1,25-(OH) 2 vitamin D 3 prenephrectomy, baseline pre-experiment, and end (post) experiment times. The end experiment values were obtained during the last hour of the experiment. Table 3 displays the levels observed in both groups. As demonstrated, bilateral nephrectomy resulted in significant declines in 1,25-(OH) 2 D 3 levels in both groups. In the sham RAD-treated animals this value declined significantly further to 15.1 Ϯ 1.5 pg/ml (P Ͻ 0.02) during the last hour of the experimental protocol, whereas RAD treatment maintained postnephrectomy pre-experiment vitamin D 3 levels.
The assessment of the influence of the RAD on plasma cytokines was limited to the pro-inflammatory cytokine (TNF-␣), the anti-inflammatory cytokine (IL-10), and C-reactive protein due to lack of availability of canine-specific reagents. Serum TNF-␣ levels rose rapidly after bacterial infusion to reach peak values at hour 2 and quickly returned to near baseline levels by hour 6 ( Figure 5 ). No significant differences were found between the values observed in the cell RAD and sham RAD groups for either the peak levels or values during the entire treatment time course. A different response was observed in the serum levels of IL-10 ( Figure 6 ). The peak levels at 2 h after bacterial administration were similar in the two groups, but a persistently higher elevation during the entire treatment interval was observed in the cell RAD animals versus the controls. The comparison of these values between the two groups demonstrated significantly higher levels (P Ͻ 0.01) in the cell RAD group compared with the sham RAD group. Correlations of IL-10 levels to various cardiovascular parameters, including cardiac outputs, in all animals did not reach statistical significance. C-reactive protein was also measured in these animals as a general assessment of the acute phase response to sepsis. As displayed in Figure 7 , C-reactive protein levels declined acutely in the first hour after bacterial seeding. These levels subsequently increased in both groups, with the cell RAD group having slightly but not significantly higher values compared with the sham control group at time points after 2 h.
Discussion
Improved treatment regimens in patients with acute renal failure in the intensive care unit (ICU) have not shared the same quantum leaps of progress that have been seen in other illnesses, such as myocardial infarction, despite improved understanding of the pathophysiology of the syndrome, improvements in mechanical ventilation, detection and treatment of infection, and techniques for renal substitution (1,2) . In this regard, the cause of death in these patients is usually the development of a systemic inflammatory response syndrome (SIRS), often secondary to sepsis, with resulting cardiovascular collapse, ischemic damage to vital organs, and multi-organ failure (MOF) (12) . The propensity of patients with ARF to develop SIRS and sepsis suggests that renal function, specifically renal tubule cell function secondary to ATN, plays a critical immunomodulatory role in individuals under stress states. The renal tubule cell's roles in glutathione reclamation, glutathione peroxidase synthesis, other middle molecule metabolism, and activation of vitamin D 3 , with its important immunoregulatory functions, are well recognized pathways to maintain important tissue integrity and host defense under stress conditions (13) . A less recognized role of the kidney and the renal tubule cells is its potential immunoregulatory function. The kidney is derived embryologically from dorsal mesoderm, a collection of cells also important in the development of bone marrow stem cells (14, 15) . The maturation of cells responsible for erythropoietin synthesis and activation of 1,25-(OH) 2 vitamin D 3 in the kidney is reflective of this embryonic origin. Phylogenetically, in bony fish and amphibians without lymph systems, the kidney is the major antibody-producing organ (15) (16) (17) . Not surprisingly, mammalian renal proximal tubule cells are immunologically active. They are antigen-presenting cells (18 -20) that possess costimulatory molecules (21) and that synthesize and process a variety of inflammatory cytokines (22) (23) (24) (25) (26) .
Acute renal failure and acute tubular necrosis that results in this loss of the kidney's immunoregulatory function results in a propensity to develop SIRS, sepsis, MOF, and a high risk of death. A counterpart to this loss of immunologic function has been clearly seen in chronic renal insufficiency and end-stage renal disease, which are clearly pro-inflammatory states (27- a Values expressed as mean Ϯ SEM (n ϭ 6 for both groups).
29). The degree of inflammation in these patient populations has been highly correlated to mortality rates (28, 29) . The loss of renal tubular cells, rather than loss of filtration and clearance function, may be the cause of this inflammatory dysregulation observed in these patients as well.
In the past decade, a large constellation of data has provided new insights into the inflammatory response that seems to underlie the MOF syndrome. There are now data linking patient outcome to initial plasma levels of TNF-␣, IL-6, and other pro-inflammatory cytokines (30 -32) . There is also increasing agreement that organ dysfunction in sepsis arises from oscillating patterns of inflammation from systemic spread of mediators beyond their usual autocrine or paracrine pathways, alternating with immunosuppression either as compensation for or exhaustion of the inflammatory response. This futile and lethal state of affairs has been referred to as "immunologic dissonance" (33,34). This paradigm has led to efforts to interrupt this process by targeting individual elements in the cascade or by reducing the overall burden of inflammatory mediators by plasma replacement or adsorption. Other approaches, including plasmapheresis, plasma exchange, hemofiltration, or monoclonal antibodies directed at various components of the inflammatory cascade, have not consistently demonstrated clinically useful interruption of the inflammatory cascade, despite promising in vitro and animal studies (35) (36) (37) (38) (39) (40) (41) . This report provides data that support the view that the renal proximal tubule has immunomodulatory effects and influences systemic cytokine patterns, and that therapy with renal tubule cells can ameliorate some of the hemodynamic instability seen with septic shock. Animals treated with a cell RAD had significantly higher systolic BP and cardiac outputs compared with those treated with sham, non-cell cartridges. The higher cardiac outputs in the dogs receiving cell therapy occurred despite left ventricular filling pressures, as reflected in PCWP, similar to those in the sham controls. In fact, in the hour before death, animals treated with a sham RAD developed large declines in cardiac output despite rising filling pressures. Most significant of all is that despite identical volume resuscitation protocols, animals treated with renal tubule cells in the BAK survived significantly longer than animals treated with a cellfree sham device.
The precise mechanisms by which this enhanced survival and the improved hemodynamics are affected are currently being evaluated. Possible mechanisms include metabolism or disposal of circulating myocardial depressants in sepsis, changes in inflammatory cytokine balance, relief of oxidant stress by glutathione reclamation, and production of free-radical scavengers (3, 13) . To evaluate the possible involvement of the tubule cells in the BAK in modulating the inflammatory response in Gram-negative septic shock, TNF-␣, IL-10, and CRP plasma levels were evaluated and compared in the two animal groups during the experimental protocol. The evaluation was limited to only these three inflammatory proteins because of the lack of reagents having cross-reactivity to dog cytokine proteins. No difference in the levels of the proinflammatory cytokine, TNF-␣, was observed in these studies. CRP levels were slightly higher in the cell-treated group after the initial decline seen in the first hour of bacterial infusion. Of importance, IL-10 levels displayed a significantly persistent elevation during the entire treatment interval in the RAD- treated group compared with sham controls. These higher IL-10 levels, however, did not correlate to the better cardiovascular parameters observed in the cell-treated animals compared with the controls. The role of IL-10 in regulating immune response continues to be elucidated, but data suggest that IL-10 levels have an influence on outcome from Gram-negative sepsis. Several reports have demonstrated that administration of recombinant IL-10 is protective against Gram-negative septic shock in murine sepsis models (42) (43) (44) . Another study in a similar model demonstrated that administration of antibodies to IL-10 was associated with higher mortality (45) . The mechanism underlying the link between proximal tubule function and IL-10 levels remains to be detailed, but preliminary data suggest that renal production of IL-6 induces liver production of IL-10 (46). Further support for an immunomodulatory role of renal tubule cells has been suggested in preliminary reports from an ongoing phase I/II clinical trial in ICU patients with ARF being treated with CVVH and a RAD containing human renal tubule cells (47, 48) .
These initial pilot experiments demonstrate the positive effect that renal tubule cell therapy and the bioartificial kidney have on the devastating consequences of bacteremia and septic shock in an acutely uremic state. The use of stem or progenitor cells is being increasingly considered as a potential approach to the treatment of a variety of acute and chronic disease states (49). The potential success of this therapeutic approach lies in the growing appreciation that most disease processes are not due to the lack of a single protein but develop due to alterations in complex interactions of a variety of cell products. Cell therapy is dependent on cell and tissue culture methodologies to expand specific cells to replace important differentiated processes deranged or lost in various disease states. Recent approaches have made progress by placing cells into hollow fiber bioreactors or encapsulating membranes as a means to deliver cell activities to a patient. Extracorporeal liver-assist devices and encapsulated Islet of Langerhans to treat liver failure and diabetes mellitus are the most notable examples (50, 51) . A reasonable extension of this approach is to add cell therapy to the current renal substitution processes of hemodialysis and hemofiltration in the acute renal failure state. These results suggest a potential utility of this approach in a well-established large animal model of septic shock and acute uremia.
